These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 11170636)
1. Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure-activity relationships. Guz NR; Stermitz FR; Johnson JB; Beeson TD; Willen S; Hsiang J; Lewis K J Med Chem; 2001 Jan; 44(2):261-8. PubMed ID: 11170636 [TBL] [Abstract][Full Text] [Related]
2. 5'-Methoxyhydnocarpin-D and pheophorbide A: Berberis species components that potentiate berberine growth inhibition of resistant Staphylococcus aureus. Stermitz FR; Tawara-Matsuda J; Lorenz P; Mueller P; Zenewicz L; Lewis K J Nat Prod; 2000 Aug; 63(8):1146-9. PubMed ID: 10978214 [TBL] [Abstract][Full Text] [Related]
3. Flavonoids as P-gp Inhibitors: A Systematic Review of SARs. Cui J; Liu X; Chow LMC Curr Med Chem; 2019; 26(25):4799-4831. PubMed ID: 30277144 [TBL] [Abstract][Full Text] [Related]
4. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor. Stermitz FR; Lorenz P; Tawara JN; Zenewicz LA; Lewis K Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1433-7. PubMed ID: 10677479 [TBL] [Abstract][Full Text] [Related]
6. Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. Sabatini S; Gosetto F; Manfroni G; Tabarrini O; Kaatz GW; Patel D; Cecchetti V J Med Chem; 2011 Aug; 54(16):5722-36. PubMed ID: 21751791 [TBL] [Abstract][Full Text] [Related]
7. Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus. Kumar A; Khan IA; Koul S; Koul JL; Taneja SC; Ali I; Ali F; Sharma S; Mirza ZM; Kumar M; Sangwan PL; Gupta P; Thota N; Qazi GN J Antimicrob Chemother; 2008 Jun; 61(6):1270-6. PubMed ID: 18334493 [TBL] [Abstract][Full Text] [Related]
8. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump. Sabatini S; Kaatz GW; Rossolini GM; Brandini D; Fravolini A J Med Chem; 2008 Jul; 51(14):4321-30. PubMed ID: 18578473 [TBL] [Abstract][Full Text] [Related]
9. Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus. Kaatz GW; Seo SM; O'Brien L; Wahiduzzaman M; Foster TJ Antimicrob Agents Chemother; 2000 May; 44(5):1404-6. PubMed ID: 10770791 [TBL] [Abstract][Full Text] [Related]
10. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators. Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123 [TBL] [Abstract][Full Text] [Related]
11. 1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors. Hequet A; Burchak ON; Jeanty M; Guinchard X; Le Pihive E; Maigre L; Bouhours P; Schneider D; Maurin M; Paris JM; Denis JN; Jolivalt C ChemMedChem; 2014 Jul; 9(7):1534-45. PubMed ID: 24677763 [TBL] [Abstract][Full Text] [Related]
12. Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance. Sabatini S; Gosetto F; Iraci N; Barreca ML; Massari S; Sancineto L; Manfroni G; Tabarrini O; Dimovska M; Kaatz GW; Cecchetti V J Med Chem; 2013 Jun; 56(12):4975-89. PubMed ID: 23710549 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of Phyllanthus amarus Schumach. & Thonn and inhibition of the NorA efflux pump of Staphylococcus aureus by Phyllanthin. Braga Ribeiro AM; Sousa JN; Costa LM; Oliveira FAA; Dos Santos RC; Silva Nunes AS; da Silva WO; Marques Cordeiro PJ; de Sousa Lima Neto J; de Siqueira-Júnior JP; Kaatz GW; Barreto HM; de Oliveira AP Microb Pathog; 2019 May; 130():242-246. PubMed ID: 30876871 [TBL] [Abstract][Full Text] [Related]
14. Aureobasidins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC-transporter. Tiberghien F; Kurome T; Takesako K; Didier A; Wenandy T; Loor F J Med Chem; 2000 Jun; 43(13):2547-56. PubMed ID: 10891114 [TBL] [Abstract][Full Text] [Related]
15. A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. Gibbons S; Oluwatuyi M; Kaatz GW J Antimicrob Chemother; 2003 Jan; 51(1):13-7. PubMed ID: 12493782 [TBL] [Abstract][Full Text] [Related]
16. From 6-aminoquinolone antibacterials to 6-amino-7-thiopyranopyridinylquinolone ethyl esters as inhibitors of Staphylococcus aureus multidrug efflux pumps. Pieroni M; Dimovska M; Brincat JP; Sabatini S; Carosati E; Massari S; Kaatz GW; Fravolini A J Med Chem; 2010 Jun; 53(11):4466-80. PubMed ID: 20446747 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of functionalized 2-aryl-5-nitro-1H-indoles and their activity as bacterial NorA efflux pump inhibitors. Samosorn S; Bremner JB; Ball A; Lewis K Bioorg Med Chem; 2006 Feb; 14(3):857-65. PubMed ID: 16203150 [TBL] [Abstract][Full Text] [Related]
18. Amino acid amides of piperic acid (PA) and 4-ethylpiperic acid (EPA) as NorA efflux pump inhibitors of Staphylococcus aureus. Wani NA; Singh S; Farooq S; Shankar S; Koul S; Khan IA; Rai R Bioorg Med Chem Lett; 2016 Sep; 26(17):4174-8. PubMed ID: 27503686 [TBL] [Abstract][Full Text] [Related]